Page last updated: 2024-11-11

5,7,4'-trihydroxy-8-methoxyflavone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4'-hydroxywogonin: from Verbena officinalis [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5322078
CHEMBL ID245712
SCHEMBL ID738981
MeSH IDM0246303

Synonyms (23)

Synonym
57096-02-3
4h-1-benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-methoxy-
5,7-dihydroxy-2-(4-hydroxyphenyl)-8-methoxy-4h-1-benzopyran-4-one
5,7,4'-trihydroxy-8-methoxyflavone
CHEMBL245712
LMPK12111363
4'-hydroxywogonin
isoscutellarein 8-methyl ether
5,7-dihydroxy-2-(4-hydroxyphenyl)-8-methoxychromen-4-one
SCHEMBL738981
DTXSID80205713
AKOS028108779
bdbm50482097
4''-hydroxywogonin
8-methoxyapigenin
f 36; isoscutellarein 8-methyl ether
XH173145
CS-0017861
HY-N1904
4 inverted exclamation marka-hydroxywogonin
AC-34656
4/'-hydroxywogonin
FS-10031
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID305359Inhibition of influenza A/Guizhou/54/89(H3N2) virus sialidase after 10 mins by fluorometric assay2007Bioorganic & medicinal chemistry letters, Feb-01, Volume: 17, Issue:3
Anti-influenza virus activity of biflavonoids.
AID305360Inhibition of influenza B/Ibaraki/2/85 virus sialidase after 10 mins by fluorometric assay2007Bioorganic & medicinal chemistry letters, Feb-01, Volume: 17, Issue:3
Anti-influenza virus activity of biflavonoids.
AID1191652Toxicity against mouse RAW264.7 cells at 30 uM after 24 hrs in absence of LPS by MTT assay2015Bioorganic & medicinal chemistry letters, Mar-01, Volume: 25, Issue:5
Anti-inflammatory activity of phenolic compounds from the whole plant of Scutellaria indica.
AID1191650Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production by Griess reaction based method2015Bioorganic & medicinal chemistry letters, Mar-01, Volume: 25, Issue:5
Anti-inflammatory activity of phenolic compounds from the whole plant of Scutellaria indica.
AID481717Inhibition of Influenza A PR/8/34 H1N1 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors.
AID1191651Toxicity against mouse RAW264.7 cells at 30 uM after 24 hrs in presence of LPS by MTT assay2015Bioorganic & medicinal chemistry letters, Mar-01, Volume: 25, Issue:5
Anti-inflammatory activity of phenolic compounds from the whole plant of Scutellaria indica.
AID305358Inhibition of influenza A/PR/8/34(H1N1) virus sialidase after 10 mins by fluorometric assay2007Bioorganic & medicinal chemistry letters, Feb-01, Volume: 17, Issue:3
Anti-influenza virus activity of biflavonoids.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (25.00)18.2507
2000's4 (33.33)29.6817
2010's4 (33.33)24.3611
2020's1 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.06 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.06)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]